Use of a pro-fibrogenic mechanism-based predictive toxicological approach for tiered testing and decision analysis of carbonaceous nanomaterials.

Engineered carbonaceous nanomaterials (ECNs), including single-wall carbon nanotubes (SWCNTs), multiwall carbon nanotubes (MWCNTs), graphene, and graphene oxide (GO), are potentially hazardous to the lung. With incremental experience in the use of predictive toxicological approaches, seeking to relate ECN physicochemical properties to adverse outcome pathways (AOPs), it is logical to explore the existence of a common AOP that allows comparative analysis of broad ECN categories. We established an ECN library comprising three different types of SWCNTs, graphene, and graphene oxide (two sizes) for comparative analysis according to a cell-based AOP that also plays a role in the pathogenesis of pulmonary fibrosis. SWCNTs synthesized by Hipco, arc discharge and Co-Mo catalyst (CoMoCAT) methods were obtained in their as-prepared (AP) state, following which they were further purified (PD) or coated with Pluronic F108 (PF108) or bovine serum albumin (BSA) to improve dispersal and colloidal stability. GO was prepared as two sizes, GO-small (S) and GO-large (L), while the graphene samples were coated with BSA and PF108 to enable dispersion in aqueous solution. In vitro screening showed that AP- and PD-SWCNTs, irrespective of the method of synthesis, as well as graphene (BSA) and GO (S and L) could trigger interleukin-1β (IL-1β) and transforming growth factor-β1 (TGF-β1) production in myeloid (THP-1) and epithelial (BEAS-2B) cell lines, respectively. Oropharyngeal aspiration in mice confirmed that AP-Hipco tubes, graphene (BSA-dispersed), GO-S and GO-L could induce IL-1β and TGF-β1 production in the lung in parallel with lung fibrosis. Notably, GO-L was the most pro-fibrogenic material based on rapid kinetics of pulmonary injury. In contrast, PF108-dispersed SWCNTs and -graphene failed to exert fibrogenic effects. Collectively, these data indicate that the dispersal state and surface reactivity of ECNs play key roles in triggering a pro-fibrogenic AOP, which could prove helpful for hazard ranking and a proposed tiered testing approach for large ECN categories.

[1]  Jianfei Jiang,et al.  Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. , 2004, Free radical biology & medicine.

[2]  Huajian Gao,et al.  Graphene microsheets enter cells through spontaneous membrane penetration at edge asperities and corner sites , 2013, Proceedings of the National Academy of Sciences.

[3]  Zongxi Li,et al.  Surface charge and cellular processing of covalently functionalized multiwall carbon nanotubes determine pulmonary toxicity. , 2013, ACS nano.

[4]  T. Webb,et al.  Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  Meiying Wang,et al.  NADPH Oxidase-Dependent NLRP3 Inflammasome Activation and its Important Role in Lung Fibrosis by Multiwalled Carbon Nanotubes. , 2015, Small.

[6]  S. Khondaker,et al.  Oxygenated Functional Group Density on Graphene Oxide: Its Effect on Cell Toxicity , 2013 .

[7]  N. K. Jain,et al.  Pulmonary toxicity of carbon nanotubes: a systematic report. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[8]  P. Baron,et al.  Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[9]  Claudio Luchinat,et al.  Mechanisms of Gadographene-Mediated Proton Spin Relaxation. , 2013, The journal of physical chemistry. C, Nanomaterials and interfaces.

[10]  T. Xia,et al.  Pluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injury. , 2012, Nano letters.

[11]  Nelson Durán,et al.  Nanotoxicity of graphene and graphene oxide. , 2014, Chemical research in toxicology.

[12]  Liangzhu Feng,et al.  Graphene in biomedicine: opportunities and challenges. , 2011, Nanomedicine.

[13]  A. Green,et al.  Sorting single-walled carbon nanotubes by electronic type using nonionic, biocompatible block copolymers. , 2010, ACS nano.

[14]  Ligeng Xu,et al.  Acute pulmonary and moderate cardiovascular responses of spontaneously hypertensive rats after exposure to single-wall carbon nanotubes , 2012, Nanotoxicology.

[15]  V. Castranova,et al.  Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus? , 2009, Pharmacology & therapeutics.

[16]  Yingying Xu,et al.  Biocompatibility of graphene oxide intravenously administrated in mice—effects of dose, size and exposure protocols , 2015 .

[17]  P. Baron,et al.  Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[18]  Chunhai Fan,et al.  Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration , 2011 .

[19]  Ivana Fenoglio,et al.  Effect of chemical composition and state of the surface on the toxic response to high aspect ratio nanomaterials. , 2011, Nanomedicine.

[20]  J. Bonner Mesenchymal cell survival in airway and interstitial pulmonary fibrosis , 2010, Fibrogenesis & tissue repair.

[21]  Mark C Hersam,et al.  Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. , 2011, Nano letters.

[22]  Y. Liu,et al.  Understanding the toxicity of carbon nanotubes. , 2013, Accounts of chemical research.

[23]  Donald R McCrimmon,et al.  Biocompatible nanoscale dispersion of single-walled carbon nanotubes minimizes in vivo pulmonary toxicity. , 2010, Nano letters.

[24]  Lei Wang,et al.  Graphene oxide induces toll-like receptor 4 (TLR4)-dependent necrosis in macrophages. , 2013, ACS nano.

[25]  Vincent Castranova,et al.  Dispersal state of multiwalled carbon nanotubes elicits profibrogenic cellular responses that correlate with fibrogenesis biomarkers and fibrosis in the murine lung. , 2011, ACS nano.

[26]  T. Meade,et al.  Graphene Oxide Enhances Cellular Delivery of Hydrophilic Small Molecules by Co-incubation , 2014, ACS nano.

[27]  B. van Ravenzwaay,et al.  Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black , 2013, Particle and Fibre Toxicology.

[28]  Meiying Wang,et al.  The Adjuvant Effect of Ambient Particulate Matter Is Closely Reflected by the Particulate Oxidant Potential , 2009, Environmental health perspectives.

[29]  A. Bianco Graphene: Safe or Toxic? The Two Faces of the Medal , 2013 .

[30]  Vincent Castranova,et al.  Quantitative techniques for assessing and controlling the dispersion and biological effects of multiwalled carbon nanotubes in mammalian tissue culture cells. , 2010, ACS nano.

[31]  Mara Ghiazza,et al.  Physico-chemical features of engineered nanoparticles relevant to their toxicity , 2010, Nanotoxicology.

[32]  M. Hersam,et al.  Colloidal properties and stability of graphene oxide nanomaterials in the aquatic environment. , 2013, Environmental science & technology.

[33]  Tian Xia,et al.  NLRP3 inflammasome activation induced by engineered nanomaterials. , 2013, Small.

[34]  Yanli Chang,et al.  Effect of size and dose on the biodistribution of graphene oxide in mice. , 2012, Nanomedicine.

[35]  K. Novoselov,et al.  Exploring the Interface of Graphene and Biology , 2014, Science.